Related Experiment Video
Updated: Feb 10, 2026

In Vivo Targeting of Xenografted Human Cancer Cells with Functionalized Fluorescent Silica Nanoparticles in Zebrafish
Published on: May 8, 2020
Macroporous silica nanoparticles for delivering Bcl2-function converting peptide to treat multidrug resistant-cancer
Weixia Xu1, Pengjin Ge1, Boning Niu1
1School of Pharmaceutical Sciences, and Fujian Provincial Key Laboratory of Innovative Drug Target Research, Xiamen University, Xiang'an South Road, Xiamen, Fujian 361102, China.
Abstract:
The abundance of B cell lymphoma gene 2 (Bcl-2) is closely correlated with the resistance of cancer cells to chemotherapeutic agents, and a peptide derived from orphan nuclear receptor Nur77 can convert Bcl-2 from a protector to a killer of cancer cells. However, successful application of the Bcl-2-converting peptide to treat drug-resistant cancer cells depends on an efficient delivery carrier. Mesoporous silica nanoparticles (MSNs) have been extensively studied as promising candidates for small molecule drug delivery. However, the effective encapsulation and intracellular delivery of peptides using small pore-sized MSNs still remain a great technical challenge. In this paper, an effective delivery platform for Bcl-2-converting peptide was fabricated by us to treat multidrug resistant-cancer cells via tuning the surface functionality of macroporous silica nanoparticles. The resulting large-sized pore silica nanoparticles, especially those modified with thiol group, exhibited the high Bcl-2-converting peptide-loading efficiency of over 40%. Moreover, the peptide induced MCF7/DOX cells into apoptotic status by penetrating cytomembrane into mitochondria and being bound with Bcl-2 to expose the BH3 domain with the aid of various surface functionalities-decorated MSNs. In particular, amine-modified surface of MSNs caused the greater influence on the cell apoptosis-inducing effects of peptide in comparison with other functionalities-modified ones. Taken together, our study, for the first time, demonstrates a special approach towards pore size and surface functionality-collectively modulated silica-based nanostructural material for effective delivery of bio-macromolecules (e.g., Bcl-2-converting peptide) to treat the multidrug resistant-cancer cells with elevated Bcl-2 levels.
Insights
Researchers developed macroporous silica nanoparticles to deliver a peptide that converts cancer-protective Bcl-2 into a killer. This novel drug delivery platform effectively treats multidrug-resistant cancer cells by enhancing peptide delivery and efficacy.
Area of Science:
- Biomaterials Science
- Nanotechnology
- Cancer Biology
Background:
- B cell lymphoma gene 2 (Bcl-2) promotes cancer cell survival and chemoresistance.
- A peptide from orphan nuclear receptor Nur77 can reverse Bcl-2's function, turning it into a cancer cell killer.
- Efficient delivery of therapeutic peptides to cancer cells remains a significant challenge, especially with traditional small-pore nanoparticles.
Purpose of the Study:
- To engineer a novel delivery platform for a Bcl-2-converting peptide.
- To overcome limitations of small-pore mesoporous silica nanoparticles for peptide delivery.
- To investigate the role of pore size and surface functionality in nanoparticle-mediated peptide delivery for treating multidrug-resistant cancer.
Main Methods:
- Fabrication of macroporous silica nanoparticles (MSNs) with tunable pore sizes and surface functionalities.
- Modification of MSNs with thiol and amine groups to enhance peptide loading and cellular uptake.
- Evaluation of peptide encapsulation efficiency and intracellular delivery into MCF7/DOX cancer cells.
- Assessment of peptide-induced apoptosis via mitochondrial targeting and Bcl-2 BH3 domain exposure.
Main Results:
- Macroporous silica nanoparticles demonstrated high peptide-loading efficiency (>40%), particularly with thiol modification.
- Surface-functionalized MSNs facilitated peptide penetration into cancer cells and mitochondria.
- The peptide successfully bound to Bcl-2, exposing the BH3 domain and inducing apoptosis.
- Amine-modified MSNs showed a pronounced effect on peptide-induced apoptosis compared to other modifications.
Conclusions:
- Engineered macroporous silica nanoparticles provide an effective platform for delivering Bcl-2-converting peptides.
- Tuning nanoparticle pore size and surface functionality is crucial for efficient delivery of biomacromolecules.
- This approach offers a promising strategy for treating multidrug-resistant cancers with elevated Bcl-2 levels.
More Related Videos
09:29In Vivo Investigation of Antimicrobial Blue Light Therapy for Multidrug-resistant Acinetobacter baumannii Burn Infections Using Bioluminescence Imaging
Published on: April 28, 2017
09:43Preparation of Silica Nanoparticles Through Microwave-assisted Acid-catalysis
Published on: December 16, 2013
Related Concept Videos
Treatment Resistant Cancers
Peptide Bonds
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors
Resistivity
Resistance
Silica Gel Column Chromatography: Overview
Polar components tend to bind strongly to the silica gel, causing them to move slowly through the column. In contrast, nonpolar compounds...